文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging.

作者信息

Eder Ann-Christin, Omrane Mohamed A, Stadlbauer Sven, Roscher Mareike, Khoder Wael Y, Gratzke Christian, Kopka Klaus, Eder Matthias, Meyer Philipp T, Jilg Cordula A, Ruf Juri

机构信息

Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Division of Radiopharmaceutical Development, German Cancer Consortium (DKTK), partner site Freiburg, Freiburg, Germany and German Cancer Research Center, Heidelberg, Germany.

出版信息

Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2057-2058. doi: 10.1007/s00259-020-05184-0. Epub 2021 Jan 23.

DOI:10.1007/s00259-020-05184-0
PMID:33486568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8113185/
Abstract
摘要

相似文献

[1]
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging.

Eur J Nucl Med Mol Imaging. 2021-6

[2]
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.

Eur Urol Focus. 2016-11-15

[3]
Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?

Nucl Med Commun. 2020-11

[4]
Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.

Eur J Nucl Med Mol Imaging. 2018-10-22

[5]
Gallium-68-prostate-specific membrane antigen ( Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.

BJU Int. 2019-4-7

[6]
Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.

Prostate. 2019-4-23

[7]
Detection Efficacy of Hybrid Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria.

J Nucl Med. 2017-2-16

[8]
In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?

Nucl Med Commun. 2020-2

[9]
Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer.

Eur J Nucl Med Mol Imaging. 2018-5-3

[10]
Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.

J Nucl Med. 2017-11-9

引用本文的文献

[1]
Intraoperative Confocal Laser Endomicroscopy Detects Prostate Cancer at the Single-Cell Level with High Specificity and in Real Time: A Preclinical Proof of Concept.

Pharmaceuticals (Basel). 2025-6-4

[2]
Advancements in molecular imaging probes for precision diagnosis and treatment of prostate cancer.

J Zhejiang Univ Sci B. 2025-1-15

[3]
Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives.

Pharmaceuticals (Basel). 2025-1-22

[4]
Lessons learned in application driven imaging agent design for image-guided surgery.

Eur J Nucl Med Mol Imaging. 2024-8

[5]
Prostate-specific membrane antigen-targeted surgery in prostate cancer: Accurate identification, real-time diagnosis, and precise resection.

Theranostics. 2024

[6]
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel.

Eur J Nucl Med Mol Imaging. 2024-8

[7]
State of the Art in Prostate-specific Membrane Antigen-targeted Surgery-A Systematic Review.

Eur Urol Open Sci. 2023-6-16

[8]
Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes.

Pharmaceuticals (Basel). 2023-3-7

[9]
The current status and future prospects for molecular imaging-guided precision surgery.

Cancer Imaging. 2022-9-6

[10]
Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives.

Pharmaceuticals (Basel). 2022-3-31

本文引用的文献

[1]
Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer.

J Nucl Med. 2018-9-20

[2]
Robot-assisted laparoscopic surgery using DROP-IN radioguidance: first-in-human translation.

Eur J Nucl Med Mol Imaging. 2018-7-27

[3]
PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer.

J Nucl Med. 2017-11-30

[4]
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Eur J Nucl Med Mol Imaging. 2015-2

[5]
68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.

Bioconjug Chem. 2012-3-13

[6]
Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.

J Urol. 2007-3

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索